The Global Nephrology and Urology Devices Market size is expected to reach $8.5 billion by 2030, rising at a market growth of 6.3% CAGR during the forecast period. In the year 2022, the market attained a volume of 1,32,278.2 thousand units experiencing a growth of 5.9% (2019-2022).
As it is utilized in a variety of urological issues (e.g., decompression of the perinephric or nephric fluid collection, complications following renal transplants, and urinary fistulas and abnormal connections between the urinary system and other structures (e.g., the skin or intestines), PCN catheters assist in the management of these conditions. Consequently, the PCN Catheters segment would generate approximately 9.68% share of the market by 2030. Therefore, the market is anticipated to be propelled by the rising incidence of urological ailments, including cervical cancer, and the benefits provided by PCN catheters. Some of the factors affecting the market are increasing incidence of kidney and urological disorders, ongoing technological innovations and advancements, and high-cost association and affordability.
According to the National Library of Medicine, chronic kidney disease is a progressive disease affecting>10% of the population globally, amounting to >800 million people. Chronic kidney disease is common in older individuals, women, racial minorities, and people experiencing diabetes mellitus and hypertension. The overall burden of kidney and urological disorders, including chronic kidney disease (CKD), kidney stones, urinary tract infections, and urological cancers, is escalating. Thus, the increasing incidence of kidney and urological disorders is a pivotal factor positively influencing the market. Moreover, Technological advancements have led to the development of minimally invasive surgical techniques in urology, including laparoscopy and robotic-assisted surgeries. These approaches reduce patient recovery times, minimize scarring, and improve surgical outcomes. Advanced imaging modalities, such as 3D imaging and virtual reality, enhance visualization capabilities during urological procedures. Due to the continuous evolution of technology, the market is expected to grow.
Additionally, the pandemic prompted a shift In healthcare delivery towards home-based and remote care. For nephrology patients, this meant an increased interest in home dialysis solutions and wearable devices for remote monitoring. Companies offering home-based nephrology solutions saw a surge in demand. Telehealth became a crucial tool for healthcare delivery during the pandemic. Nephrologists and urologists turned to virtual consultations for non-emergency cases and routine follow-ups. As a result, due to these changes, the market is expected to grow significantly in the coming years.
However, High upfront costs for acquiring nephrology and urology devices may limit access to smaller healthcare facilities, clinics, or those in resource-constrained settings. This can lead to disparities in the availability of advanced technologies across different healthcare settings. The substantial investment required to purchase and maintain sophisticated nephrology and urology devices can strain the financial resources of healthcare systems. Hospitals and healthcare providers may face budget constraints that hinder their ability to invest in expensive equipment. Due to the above factors, market growth will be hampered in the coming years.
By end-use, the market is classified into hospitals, clinics, ambulatory surgical centers, and others. In 2022, the hospitals segment registered the highest revenue share in the market in 2022. Owing to their advanced infrastructure and availability of equipment for the diagnosis and treatment of kidney diseases and urological disorders. Teaching hospitals affiliated with medical schools or universities often strongly emphasize providing comprehensive medical services, including specialized care in nephrology and urology. These institutions may invest in cutting-edge devices for education and research purposes. Hospitals offer various services, including dialysis, surgery, and other specialized treatments. In addition, the rising need for minimally invasive procedures further propels segment growth.
Based on application, the market is fragmented into urolithiasis, urological cancer & BPH, bladder disorders, kidney diseases, and others. The urological cancer & BPH segment procured a promising growth rate in the nephrology and urology devices market in 2022. Urological cancers are among the most common cancers worldwide. As per a report by the American Cancer Society in January 2023, bladder cancer ranks fourth in terms of cancer incidence in men. BPH is also a prevalent condition, affecting over half of the male population over the age of 50. Significant technological advancements in urology in recent years have led to the development of more effective and minimally invasive devices for diagnosing and treating urological cancer and BPH.
On the basis of product, the market is segmented into ureteral catheters, PCN catheters, urinary stents, stone baskets, urology guidewires, renal dilators, mesh & inserts, and others. In 2022, the urology guidewires segment dominated the market with maximum revenue share. The urology guidewire is advanced through the ureter under fluoroscopic guidance. Once the guidewire reaches the bladder, a stent is threaded over the guidewire and guided into the appropriate position within the ureter. Ureteroscopy involves the insertion of a ureteroscope into the ureter to visualize and treat conditions such as kidney stones or tumors. Guidewires aid in navigating and positioning the ureteroscope during the procedure. The urology guidewire is introduced into the ureter, and the access sheath is advanced over the wire to provide a working channel for other instruments.
| Report Attribute | Details |
|---|---|
| Market size value in 2022 | USD 5.2 Billion |
| Market size forecast in 2030 | USD 8.5 Billion |
| Base Year | 2022 |
| Historical Period | 2019 to 2021 |
| Forecast Period | 2023 to 2030 |
| Revenue Growth Rate | CAGR of 6.3% from 2023 to 2030 |
| Number of Pages | 474 |
| Number of Table | 850 |
| Quantitative Data | Volume in Thousand Units, Revenue in USD Billion, and CAGR from 2019 to 2030 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Porter’s 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives |
| Segments covered | Type, Technology, Application, Region |
| Country scope |
|
| Companies Included | Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated |
| Growth Drivers |
|
| Restraints |
|
Region-wise, the markets are analysed across North America, Europe, Asia Pacific, and LAMEA. The Asia pacific region acquired a substantial revenue share in the market in 2022. Due to many factors, including heightened awareness regarding renal and urinary disorders, escalating healthcare expenditures, and the enhancement of healthcare infrastructure in the area. The regional market is being propelled by the rising incidence of benign prostatic hyperplasia (BPH), spinal cord injury, and urinary tract infection. In this region, urinary tract infections (UTIs) are exceedingly prevalent. The increasing demand for these devices is also fueled by the critical requirement to develop new systems and supplant and improve current medical infrastructure.
Free Valuable Insights: Global Nephrology And Urology Devices Market size to reach USD 8.5 Billion by 2030
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
By End-use (Volume, Thousand Units, USD Billion, 2019-2030)
By Application (Volume, Thousand Units, USD Billion, 2019-2030)
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
By Geography (Volume, Thousand Units, USD Billion, 2019-2030)
The Market size is projected to reach USD 8.5 billion by 2030.
Ongoing technological innovations and advancements are driving the Market in coming years, however, High costs association and affordability restraints the growth of the Market.
Hollister, Inc., Medtronic PLC, Coloplast Group, Boston Scientific Corporation, ConvaTec Group PLC, Baxter International, Inc., Asahi Kasei Corporation, Cook Medical, Inc. (Cook Group), Terumo Corporation, Teleflex Incorporated
In the year 2022, the market attained a volume of 1,32,278.2 thousand units experiencing a growth of 5.9% (2019-2022).
The Kidney Diseases segment is leading the Market by Application in 2022 thereby, achieving a market value of $3 billion by 2030.
The North America region dominated the Market by Region in 2022 thereby, achieving a market value of $3.3 billion by 2030, growing at a CAGR of 5.6 % during the forecast period.
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
